Expand AKRO Menu
AKRO MENU

AKRO Latest Press Releases

-- December 9, 2025 --

Novo Nordisk has completed its acquisition of Akero Therapeutics Globe Newswire 8:51 AM

-- November 20, 2025 --

Halper Sadeh LLC Encourages SEE, AXTA, SEMR, AKRO Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 4:57 PM
Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO Business Wire 12:33 PM

-- November 18, 2025 --

Halper Sadeh LLC Encourages WOW, AKRO, HFWA, BRY Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 12:20 PM

-- November 12, 2025 --

Halper Sadeh LLC Encourages NIC, AKRO, BRNS Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 1:55 PM
Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO) PRNewswire 1:22 PM

-- November 10, 2025 --

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS PRNewswire 5:30 PM

-- November 7, 2025 --

Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 1:40 PM
Akero Therapeutics Presents New Analyses from Phase 2b SYMMETRY and HARMONY Trials of Efruxifermin at 76th Annual AASLD The Liver Meeting 2025 Globe Newswire 7:00 AM

-- November 5, 2025 --

Halper Sadeh LLC Encourages AKRO, CADE, FSUN Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 11:45 AM

-- November 4, 2025 --

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO) PRNewswire 4:41 PM

-- October 30, 2025 --

Halper Sadeh LLC Encourages AL, FFWM, AKRO, HNI Shareholders to Contact the Firm to Discuss Their Rights Globe Newswire 8:40 AM

-- October 29, 2025 --

Berger Montague PC Investigates Akero Therapeutics, Inc. and Its Board of Directors for Breach of Fiduciary Duties and Violations of Federal Securities Laws (NASDAQ: AKRO) PRNewswire 6:06 PM
Halper Sadeh LLC Encourages FFWM, AKRO, CCRD Shareholders to Contact the Firm to Discuss Their Rights PRNewswire 9:07 AM

-- October 22, 2025 --

Halper Sadeh LLC Investigates AKRO, CCRD, PBBK on Behalf of Shareholders Globe Newswire 11:23 AM

-- October 21, 2025 --

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress Globe Newswire 7:00 AM

-- October 16, 2025 --

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates TRUE, AKRO, PCH, ATXS on Behalf of Shareholders Globe Newswire 9:11 PM

-- October 14, 2025 --

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, HSII, AKRO on Behalf of Shareholders PRNewswire 12:50 PM

-- October 10, 2025 --

Akero Therapeutics Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akero Therapeutics, Inc. - AKRO Business Wire 6:14 PM

-- October 9, 2025 --

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates AKRO, CCRD, AL, PBBK on Behalf of Shareholders Globe Newswire 12:00 PM
Shareholder Alert: The Ademi Firm investigates whether Akero Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders PRNewswire 11:00 AM
AKRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akero Therapeutics, Inc. Is Fair to Shareholders Business Wire 8:00 AM
Akero Therapeutics to be Acquired by Novo Nordisk for up to $5.2 Billion Globe Newswire 6:01 AM

-- October 7, 2025 --

Akero Therapeutics to Present New Data from the Phase 2b SYMMETRY and HARMONY Studies of Efruxifermin at the 76th Annual AASLD The Liver Meeting 2025 Globe Newswire 7:00 AM

-- September 18, 2025 --

AKERO THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Akero Therapeutics, Inc. - AKRO Globe Newswire 4:15 PM

-- August 28, 2025 --

Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference Globe Newswire 7:00 AM

-- August 14, 2025 --

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH Globe Newswire 6:30 PM

-- August 8, 2025 --

Akero Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 7:15 AM
Market Data Delayed 15 Minutes